Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Potential HSV-2 vaccine described by Aviron

May 5, 1997

Novel immunosuppressants from Takeda

April 29, 1997

BioChem Pharma's novel flu vaccine meets phase I trial endpoints

April 28, 1997

MedImmune's vaccine candidate prevents urinary tract infections in preclinical studies

April 28, 1997

Antex Biologics allowed patents on adhesin receptor technology and H. influenzae protein

April 28, 1997

WF-10917: new immunosuppressant from Fujisawa

April 24, 1997

North American Vaccine's acellular pertussis vaccine approved in Sweden

April 23, 1997

Connaught prepares Bordetella vaccine

April 22, 1997

Ergo Science and Massachusetts General Hospital conclude licensing agreement

April 18, 1997

MEDI-507 heads for clinical trials

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...